Neoadjuvant Chemoimmunotherapy for NSCLC
2024 · JAMA Oncology · 169 citations
https://doi.org/10.1001/jamaoncol.2024.0057
C
Connor Prosty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
594
Citations
12
h-index
18
i10-index
Connor Prosty is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Food Allergy and Anaphylaxis Research & Urticaria and Related Conditions & Drug-Induced Adverse Reactions. The author has an h-index of 12, co-authored 68 publications.
ORCID: 0000-0001-6790-220XPapers by this author
worksSeven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection
2025 · JAMA Network Open · 12 citations
https://doi.org/10.1001/jamanetworkopen.2025.1421
Diagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
2024 · Clinical Microbiology and Infection · 9 citations
https://doi.org/10.1016/j.cmi.2024.11.004
Oral vancomycin prophylaxis for the prevention of recurrent Clostridioides difficile infection during re-exposure to systemic antibiotics: A systematic review and meta-analysis
2024 · CMI Communications · 3 citations
https://doi.org/10.1016/j.cmicom.2024.105041
Guiding Drug Provocation Testing for Ibuprofen Hypersensitivity in a Pediatric Population: Development of the I3A Risk-Stratification Tool
2024 · The Journal of Allergy and Clinical Immunology In Practice · 3 citations
https://doi.org/10.1016/j.jaip.2024.11.022
Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
2023 · Clinical and Experimental Medicine · 2 citations
https://doi.org/10.1007/s10238-023-01213-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat